Skip to main content
Book cover

The Inflammasomes

  • Book
  • © 2011

Overview

  • Overview on the current knowledge of inflammasome biology
  • Highlights the role of inflammasomes in health and disease
  • With contributions by leading international experts
  • Includes supplementary material: sn.pub/extras

Part of the book series: Progress in Inflammation Research (PIR)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (14 chapters)

Keywords

About this book

The inflammasome was first described in 2002 as a molecular complex activating proinflammatory caspases and therefore regulating the maturation and biological activities of cytokines such as IL-1 and IL-18. This finding was substantiated by the identification of several mutations in the cias1 gene, encoding the human NLRP3 protein, responsible for several autoinflammatory disorders such as the Muckle Wells syndrome. Since, the interest for this complex has constantly increased and several inflammasome complexes with different specificities have been described. These inflammasomes sense a wide variety of pathogens and danger signals and are key players in the inflammatory response. With the contributions of leading international experts in the field, this book provides an extensive overview of the current knowledge of inflammasome biology and their role in health and disease.

Editors and Affiliations

  • Institut de Transgénose, Labo. d'Immunologie et, CNRS, Orléans CX 2, France

    Isabelle Couillin

  • CNRS UMR 5201, Labo. Génétique et Cancer, Université de Lyon I, Lyon, France

    Virginie Pétrilli

  • Dept. Immunology & Infectious, Diseases, Harvard School of Public Health, Boston, USA

    Fabio Martinon

Bibliographic Information

Publish with us